Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Accured Expenses (2023 - 2025)

CG Oncology filings provide 3 years of Change in Accured Expenses readings, the most recent being $3.7 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 11.77% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.7 million, a 58.28% increase, with the full-year FY2025 number at $8.7 million, up 58.28% from a year prior.
  • Change in Accured Expenses hit $3.7 million in Q4 2025 for CG Oncology, up from -$3.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $7.5 million in Q2 2025 to a low of -$4.1 million in Q1 2024.
  • Median Change in Accured Expenses over the past 3 years was $1.6 million (2023), compared with a mean of $1.5 million.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 2712.03% in 2024 and later surged 263.53% in 2025.
  • CG Oncology's Change in Accured Expenses stood at $1.8 million in 2023, then soared by 89.98% to $3.3 million in 2024, then increased by 11.77% to $3.7 million in 2025.
  • The last three reported values for Change in Accured Expenses were $3.7 million (Q4 2025), -$3.4 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.